We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Celcuity Inc. is one of them. Celcuity Inc. (NASDAQ:CELC) is a clinical-stage biotechnology company developing ...
Advanced ER-positive breast cancer patients on giredestrant and Afinitor had better progression-free survival versus standard therapy in the evERA trial.
Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, ...
The emergence of drug resistance remains one of the greatest challenges in effective cancer therapy. Despite advances in ...
The firm, which so far has focused on cancer, expects to file an IND application for a treatment for tyrosinemia type I and alkaptonuria next year.
Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, Delivering Full Strength of Everolimus ...
Kazia Therapeutics ( ($KZIA) ) just unveiled an announcement. On September 11, 2025, Kazia Therapeutics announced significant findings from a ...
Faeth Therapeutics, a clinical-stage biotechnology company developing therapies that target tumor metabolism, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback